ArticleMolecular neurobiology2025
Pax6 Binds to NF-κB DNA Motif and Regulates Genes Involved in NF-κB Activation in the Brains of LPS-Treated Mice.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cooperation of Transcription Factor PAX6 with Chromatin-Remodeling Complex BAF During Embryonic Development in Mammals.Cellular and molecular neurobiology · 2026Review
- Gut microbiota in Henoch-Schönlein purpura: from pathogenesis to therapeutic strategies.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Lipopolysaccharide (LPS) activates the Toll-like receptor 4 (TLR4)-dependent signalling cascade, leading to nuclear translocation of NF-κB, a key transcription factor that regulates pro-inflammatory gene expression including Tnfα. However, the regulation of NF-κB and additional transcription factors in the management of neuroinflammation is not clear. This report is intended to evaluate the impacts of the Pax6 on the TLR4-dependent neuroinflammation. Chromatin immunoprecipitation (ChIP) with anti-Pax6, followed by sequencing and motif analysis, identified regulatory sequence elements. Additionally, ChIP-qPCR was performed and the expression of Pax6-binding genes was analysed using semi-quantitative PCR and western blotting in the brains of the control and LPS-treated mice. The impact of Pax6 on genes associated with NF-κB mediated inflammatory responses was estimated by siRNA-mediated knockdown and overexpression of Pax6 in the N2a cell line. The Pax6 and NF-κB (NFκB1 and RelA) have multiple binding sites on the regulatory sequence elements, which were also confirmed by sequencing. The analysis also revealed binding of Pax6 on the consensus DNA motif of NF-κB and within the regulatory sequence elements of Tlr4, Tab2 and Tank. ChIP-qPCR demonstrated increased binding capacity of Pax6 on promoter sequence elements of NFκB1, RelA, Tab2 and Tank, but decreased binding at Tlr4. The expressions of Pax6, NFκB1, RelA, Tlr4, Tab2, Tank and NF-κB inducible gene Tnfα were also altered. The expression of NFκB1, RelA, Tnfα, Tlr4, Tab2 and Tank was affected by Pax6 knockdown and overexpression. Collectively these findings suggest anti-inflammatory potential of Pax6 through NF-κB regulation.
Indexed as
Identifiers
41238989What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.